Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Risk Management and Healthcare Policy
|
May 12, 2015
Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature
Silvia Coretti, Federica Romano, Valentina Orlando, et al.
Applied Health Economics and Health Policy
|
July 25, 2018
Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy
Matteo Ruggeri, Federica Romano, Michele Basile, et al.
Journal of Nephrology
|
July 17, 2014
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study
Matteo Ruggeri, Antonio Bellasi, Filippo Cipriani, et al.
International Journal of Technology Assessment in Health Care
|
March 24, 2022
The transcatheter aortic valve implantation: an assessment of the generalizability of the economic evidences following a systematic review
Matteo Ruggeri, Mandolini Donatella, Campisi Federica, et al.
Clinical Drug Investigation
|
March 28, 2013
Economic evaluation of 5-grass pollen tablets versus placebo in the treatment of allergic rhinitis in adults
Matteo Ruggeri, Marco Oradei, Franco Frati, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 23, 2015
Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review
Matteo Ruggeri, Andrea Manca, Silvia Coretti, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Eugenio Di Brino, Matteo Ruggeri, Stefania Boccia, et al.
Clinical Drug Investigation
|
July 15, 2022
Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study
Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, et al.
Arthritis Care & Research
|
January 13, 2015
Cost-effectiveness analysis of two rituximab retreatment regimens for longstanding rheumatoid arthritis
Luca Quartuccio, Rossella di Bidino, Matteo Ruggeri, et al.
Journal of Hepatology
|
May 28, 2013
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C
Calogero Cammà, Salvatore Petta, Giuseppe Cabibbo, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Risk Management and Healthcare Policy
|
May 12, 2015
Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature
Silvia Coretti, Federica Romano, Valentina Orlando, et al.
Applied Health Economics and Health Policy
|
July 25, 2018
Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy
Matteo Ruggeri, Federica Romano, Michele Basile, et al.
Journal of Nephrology
|
July 17, 2014
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study
Matteo Ruggeri, Antonio Bellasi, Filippo Cipriani, et al.
International Journal of Technology Assessment in Health Care
|
March 24, 2022
The transcatheter aortic valve implantation: an assessment of the generalizability of the economic evidences following a systematic review
Matteo Ruggeri, Mandolini Donatella, Campisi Federica, et al.
Clinical Drug Investigation
|
March 28, 2013
Economic evaluation of 5-grass pollen tablets versus placebo in the treatment of allergic rhinitis in adults
Matteo Ruggeri, Marco Oradei, Franco Frati, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 23, 2015
Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review
Matteo Ruggeri, Andrea Manca, Silvia Coretti, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Eugenio Di Brino, Matteo Ruggeri, Stefania Boccia, et al.
Clinical Drug Investigation
|
July 15, 2022
Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study
Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, et al.
Arthritis Care & Research
|
January 13, 2015
Cost-effectiveness analysis of two rituximab retreatment regimens for longstanding rheumatoid arthritis
Luca Quartuccio, Rossella di Bidino, Matteo Ruggeri, et al.
Journal of Hepatology
|
May 28, 2013
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C
Calogero Cammà, Salvatore Petta, Giuseppe Cabibbo, et al.
Page
of 6